Loading...
XHKG
1302
Market cap780mUSD
Jul 10, Last price  
1.40HKD
1D
0.72%
1Q
-28.21%
Jan 2017
-24.73%
IPO
460.00%
Name

LifeTech Scientific Corp

Chart & Performance

D1W1MN
XHKG:1302 chart
P/E
36.08
P/S
3.89
EPS
0.03
Div Yield, %
Shrs. gr., 5y
0.13%
Rev. gr., 5y
16.35%
Revenues
1.37b
+5.07%
104,704,000140,324,000181,475,000231,035,000282,679,000311,606,000352,849,000409,125,000556,698,000668,879,000642,299,000925,334,0001,097,310,0001,267,175,0001,303,699,0001,369,779,000
Net income
148m
-33.53%
3,936,00011,830,00032,352,000-65,666,000-81,244,0002,359,000145,652,000163,472,000121,082,000129,200,000216,085,000292,472,000325,337,000263,242,000222,388,000147,827,000
CFO
555m
+72.65%
44,755,00011,790,00042,523,00034,963,00019,527,000144,313,000126,956,000154,891,000182,300,000274,986,000338,532,000488,853,000388,318,000418,049,000321,460,000555,014,953

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company’s products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. It also involved in the biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.
IPO date
Nov 10, 2011
Employees
1,393
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT